Thomas Malley, Director at Kura Oncology, Inc. (KURA), bought 50,000 shares at $11.50 ($575K) on 2023-06-16, disclosed to the SEC on 2023-06-21.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |
| KURA | BUY | 2015-12-17 | $400K | — | Filing → |
| OVAS | BUY | 2015-04-09 | $143K | — | Filing → |
| OVAS | BUY | 2015-01-15 | $1.8M | — | Filing → |